In the interests of transparency, which is one of ROVI's strategic values, the company's management team will, today on March 2sd, 2021 at 10 am (CET), share an update of the regulatory processes of its long-acting injectable antipsychotic, Doria®, both in Europe and the United States with investors and analysts.
We provide the access link that will allow you to connect to the meeting below:
https://cloudup.vancastvideo.com/event/k58myFiw/1693/?lang=1408
Martes, 02 Mar 2021